维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="Shinzoh"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial显示文摘	Tetsuya Mitsudomi Satoshi Morita Yasushi Yatabe Shunichi Negoro Isamu Okamoto Junji Tsurutani Takashi Seto Miyako Satouchi Hirohito Tada Tomonori Hirashima Kazuhiro Asami Nobuyuki Katakami Minoru Takada Hiroshige Yoshioka Kazuhiko Shibata Shinzoh Kudoh Ei	2010	Lancet Oncology2010，，2：	8
	2	Phase Ⅲ study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer:Results of the west Japan Thoracic Oncology Group Trial(WJTOG 9904)显示文摘	Shinzoh Kudoh Koji Takeda Kazuhiko Nakagawa	2006	JCO2006，24，22：	1
	3	Expression of epidermal growth factor receptor(EGFR)and downstream-activated peptides in surgically excised non-small-cell lung cancer(NSCLC)显示文摘	Tom Mukoharaa Shinzoh Kudoha Setsuko Yamauchia	2003	Lung Cancer2003，41，：	1
	4	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial显示文摘	Tetsuya Mitsudomi Satoshi Morita Yasushi Yatabe Shunichi Negoro Isamu Okamoto Junji Tsurutani Takashi Seto Miyako Satouchi Hirohito Tada Tomonori Hirashima Kazuhiro Asami Nobuyuki Katakami Minoru Takada Hiroshige Yoshioka Kazuhiko Shibata Shinzoh Kudoh Ei	2010	Lancet Oncology2010，，2：	1
	5	Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort显示文摘	Seiji Yano Tadaaki Yamada Shinji Takeuchi Keisei Tachibana Yuko Minami Yasushi Yatabe Tetsuya Mitsudomi Hidenori Tanaka Tatsuo Kimura Shinzoh Kudoh Hiroshi Nokihara Yuichiro Ohe Jun Yokota Hidetaka Uramoto Kosei Yasumoto Katsuyuki Kiura Masahiko Higashiya	2011	Journal of Thoracic Oncology2011，，12：	1
	6	Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small cell lung cancer (NSCLC) 显示文摘	Toru Mukoharaa Shinzoh Kudoha Setsuko Yamauchia	2003	Lung Cancer2003，41，：	1
	7	PhaseⅢstudy of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer:Results of the west Japan Thoracic Oncology Group Trial(WJTOG9904)显示文摘	Shinzoh Kudoh Koji Takeda Kazuhiko Nakagawa	2006	J Clin Oncol2006，24，22：	1
	8	Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation显示文摘	Naruo Yoshimura Shinzoh Kudoh Shigeki Mitsuoka Naoki Yoshimoto Takako Oka Toshiyuki Nakai Tomohiro Suzumira Kuniomi Matusura Yoshihiro Tochino Kazuhisa Asai Tatsuo Kimura Tomoya Kawaguchi Kazuto Hirata	2015	Lung Cancer2015，，1：	1
	9	EKB -569,a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor,with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib显示文摘	NARUO Y SHINZOH K TATSUO K	2006	Lung Cancer2006，51，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费